share_log

HC Wainwright & Co. Reiterates Buy on EFFECTOR Therapeutics, Maintains $24 Price Target

Moomoo 24/7 ·  Mar 28 06:12

HC Wainwright & Co. analyst Robert Burns reiterates eFFECTOR Therapeutics (NASDAQ:EFTR) with a Buy and maintains $24 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment